CRVS
Corvus Pharmaceuticals, Inc.
stockNASDAQ
At CloseOct 2, 2026 3:59:58 PM EDT
10.90USD-0.229%(-0.03)1,347,819
Pre-marketOct 2, 2026 8:16:30 AM EDT
11.00USD+0.640%(+0.07)
Loading…
Loading…
916.92M
Healthcare
Biotechnology
CEO
Richard Miller
HQ
Burlingame, CA, USA
Previous Close
$10.93
Beta
-0.40
52-Week High
$26.95 2026-01-23
52-Week Low
$6.39 2026-01-12
SMA 50
$13.49
SMA 200
$14.15
Avg. Vol 10D
1.06M
Avg. Vol 30D
1.05M
Avg. Vol 90D
1.15M
Relative Vol
1.28
84.12M
72.76M
86.49%
17,180,341
23.61%
18.16
63%/37%
41.67%
31.71%
0.2700%
300,000
3,661
4,462
19,099
Nov 3, 2026 (29d)
Sep 30, 2026
CRVS Profile
corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.
CRVS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.87 | 2026-09-28 | -8.17% | 0.988 |
| 1M | 14.39 | 2026-09-04 | -24.25% | 1.390 |
| 3M | 15.17 | 2026-07-06 | -28.15% | 1.507 |
| 6M | 14.71 | 2026-04-06 | -25.90% | 1.583 |
| 1Y | 6.98 | 2025-10-06 | +56.16% | -0.396 |
| 2Y | 5.64 | 2024-10-04 | +93.26% | — |
| 5Y | 4.72 | 2021-10-05 | +130.93% | 1.033 |
CRVS Stock Summary
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) stock price today is $10.90, and today's volume is 1,347,819. CRVS is down 0.274% today. The 30 day average volume is 1.05M. CRVS market cap is $916.92M with 84.12M shares outstanding.